LOS ANGELES CAPITAL MANAGEMENT LLC
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1177206
LOS ANGELES, CA
Position in ARWR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$47,112
-$1,267,707 QoQ
Shares Held
578
-97.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#410
of 497 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LOS ANGELES CAPITAL MANAGEMENT LLC holds $888,562,834 across 167 Biotechnology names. ARWR ranks #112 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
729,635 | $219,642,024 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,938,035 | $151,689,999 | |
| 3 | CAI |
Caris Life Sciences, Inc.
|
3,958,531 | $70,541,022 | |
| 4 | INCY |
Incyte Corp
|
578,986 | $65,633,852 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
130,802 | $64,973,277 | |
| 6 | EXEL |
Exelixis, Inc.
|
1,159,457 | $63,086,055 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
98,585 | $61,471,690 | |
| 8 | RPRX |
Royalty Pharma plc
|
877,674 | $49,211,181 |
All Filings in ARWR
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $47,112 | 578 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,314,819 | 20,970 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $1,240,563 | 18,686 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $644,480 | 18,686 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $915,578 | 57,948 | Shares | Sole | 2025-08-07 | |
| 2023-09-30 | $325,986 | 12,132 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $534,900 | 15,000 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $216,154 | 8,510 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $527,645 | 13,009 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $466,302 | 14,109 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $447,448 | 12,708 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $406,873 | 8,847 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $560,433 | 8,453 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $519,604 | 8,323 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $753,993 | 9,104 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $1,374,672 | 20,731 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $3,104,188 | 40,456 | Shares | Sole | 2021-03-10 | |
| 2020-09-30 | $1,944,847 | 45,166 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $4,880,167 | 112,993 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $3,212,745 | 111,670 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||